Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 12 Months to 48 Months

Nebulized dexmedetomidine with ketamine versus dexmedetomidine alone for sedation in children having cleft palate repair

Official title: Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine to Induce Preoperative Sedation and Attenuate Emergence Agitation in Children Undergoing Cleft Palate Repair Surgeries

Run by Assiut University · NCT05821972 · Data updated 2026-11-12

This will test whether adding ketamine to nebulized dexmedetomidine helps sedate children undergoing cleft palate repair and reduces emergence delirium.

More Sedation trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages12 Months to 48 Months
SexAll
Enrollment60 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut)
StatusRecruiting
StartedApril 10, 2024
Main results expectedOctober 20, 2025
Study endsOctober 30, 2025
Registry record updatedOctober 3, 2025
Trial IDNCT05821972 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children ASA I–II scheduled for primary cleft palate repair who have no major organ disease, no asthma or psychiatric illness, and no allergy to dexmedetomidine or ketamine.

Probably not a fit

Children with significant cardiac, renal, hepatic, or endocrine disease, asthma, psychiatric disorders, suspected difficult airway, or known allergy to the drugs are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 4 interventional comparison gives children scheduled for primary cleft palate repair a preoperative nebulized dose of either dexmedetomidine plus ketamine or dexmedetomidine alone. Participants are ASA I–II pediatric patients without major comorbidities and are monitored for sedation onset, hemodynamic effects, and emergence delirium postoperatively. Investigators record intraoperative and recovery room outcomes to compare effectiveness and side-effect profiles between the two nebulized regimens. The protocol excludes patients with suspected difficult airways, significant cardiac, hepatic, renal or endocrine disease, asthma, psychiatric disorders, or drug allergies.

Why it matters

Potential benefit: If successful, adding ketamine to nebulized dexmedetomidine could provide quicker, more stable preoperative sedation and lower the risk of emergence delirium without respiratory depression.

How similar studies have gone: Dexmedetomidine is widely used for pediatric premedication and small studies suggest ketamine can complement it, but nebulized ketamine-dexmedetomidine combinations for cleft palate premedication are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with American Society of Anesthesiologists (ASA) physical status I \& II who will be scheduled for cleft palate repair surgeries

Exclusion Criteria:

* Parent refusal
* Allergy to the study drugs
* Suspected difficult airway
* Patients with endocrine, renal, hepatic, and cardiac pathology
* Psychiatric diseases
* Asthmatic patients.

Where it's running

  • Assiut University
    Asyut, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.